You are here
Pfizer mulls spin-off or sale of consumer health unit: sources
US drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as US$14 billion, people familiar with the matter said on Wednesday.
A Pfizer exit from the consumer health business, which includes lip
CALL +65 6388 3838 EMAIL firstname.lastname@example.org